Lorcaserin Intra Venous Cocaine Effects
NCT02680288
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Cocaine Use Disorders
Interventions
DRUG:
Lorcaserin, 10 mg
DRUG:
Lorcaserin, 20 mg
OTHER:
Oral Placebo
Sponsor
Midwest Biomedical Research Foundation